AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India
· Delayed Price · Currency is INR 9,226.50
+23.50 (0.26%)
At close: Dec 5, 2025
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 230.29 billion as of December 5, 2025. Its market cap has increased by 43.98% in one year.
Market Cap
230.29B
Enterprise Value
226.64B
Revenue
20.06B
Ranking
n/a
PE Ratio
115.64
Stock Price
9,226.50
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 230.29B, an increase of 15,781.90%. That is a compound annual growth rate of 23.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,334.88B |
| Divi's Laboratories | 1,713.60B |
| Cipla | 1,228.62B |
| Apollo Hospitals Enterprise | 1,035.39B |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |